351 related articles for article (PubMed ID: 31655928)
1. Pathological features of vessel co-option versus sprouting angiogenesis.
Latacz E; Caspani E; Barnhill R; Lugassy C; Verhoef C; Grünhagen D; Van Laere S; Fernández Moro C; Gerling M; Dirix M; Dirix LY; Vermeulen PB
Angiogenesis; 2020 Feb; 23(1):43-54. PubMed ID: 31655928
[TBL] [Abstract][Full Text] [Related]
2. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
3. Models and molecular mechanisms of blood vessel co-option by cancer cells.
Zhang Y; Wang S; Dudley AC
Angiogenesis; 2020 Feb; 23(1):17-25. PubMed ID: 31628560
[TBL] [Abstract][Full Text] [Related]
4. Angiotropism, pericytic mimicry and extravascular migratory metastasis: an embryogenesis-derived program of tumor spread.
Lugassy C; Kleinman HK; Vermeulen PB; Barnhill RL
Angiogenesis; 2020 Feb; 23(1):27-41. PubMed ID: 31720876
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model.
Rada M; Lazaris A; Kapelanski-Lamoureux A; Mayer TZ; Metrakos P
Semin Cancer Biol; 2021 Jun; 71():52-64. PubMed ID: 32920126
[TBL] [Abstract][Full Text] [Related]
6. Vessel co-option in cancer.
Kuczynski EA; Vermeulen PB; Pezzella F; Kerbel RS; Reynolds AR
Nat Rev Clin Oncol; 2019 Aug; 16(8):469-493. PubMed ID: 30816337
[TBL] [Abstract][Full Text] [Related]
7. Vessel co-option and resistance to anti-angiogenic therapy.
Kuczynski EA; Reynolds AR
Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
[TBL] [Abstract][Full Text] [Related]
8. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
Qian CN; Tan MH; Yang JP; Cao Y
Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
[TBL] [Abstract][Full Text] [Related]
9. Tumour vascularization: sprouting angiogenesis and beyond.
Hillen F; Griffioen AW
Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of vascularization in murine models of primary and metastatic tumor growth.
Bugyik E; Renyi-Vamos F; Szabo V; Dezso K; Ecker N; Rokusz A; Nagy P; Dome B; Paku S
Chin J Cancer; 2016 Feb; 35():19. PubMed ID: 26873579
[TBL] [Abstract][Full Text] [Related]
11. Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
Donnem T; Hu J; Ferguson M; Adighibe O; Snell C; Harris AL; Gatter KC; Pezzella F
Cancer Med; 2013 Aug; 2(4):427-36. PubMed ID: 24156015
[TBL] [Abstract][Full Text] [Related]
12. Tumor vasculature: a sally port for inhibiting cancer cell spreading.
Qian CN; Pezzella F
Cancer Commun (Lond); 2018 Aug; 38(1):52. PubMed ID: 30075743
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?
Coelho AL; Gomes MP; Catarino RJ; Rolfo C; Lopes AM; Medeiros RM; Araújo AM
Oncotarget; 2017 Jun; 8(24):39795-39804. PubMed ID: 26950275
[TBL] [Abstract][Full Text] [Related]
14. Vessel co-option and angiotropic extravascular migratory metastasis: a continuum of tumour growth and spread?
Lugassy C; Vermeulen PB; Ribatti D; Pezzella F; Barnhill RL
Br J Cancer; 2022 Apr; 126(7):973-980. PubMed ID: 34987186
[TBL] [Abstract][Full Text] [Related]
15. Eight autopsy cases of melanoma brain metastases showing angiotropism and pericytic mimicry. Implications for extravascular migratory metastasis.
Rodewald AK; Rushing EJ; Kirschenbaum D; Mangana J; Mittmann C; Moch H; Lugassy C; Barnhill RL; Mihic-Probst D
J Cutan Pathol; 2019 Aug; 46(8):570-578. PubMed ID: 30927294
[TBL] [Abstract][Full Text] [Related]
16. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
[TBL] [Abstract][Full Text] [Related]
17. Angiotropism of human prostate cancer cells: implications for extravascular migratory metastasis.
Lugassy C; Vernon SE; Warner JW; Le CQ; Manyak M; Patierno SR; Barnhill RL
BJU Int; 2005 May; 95(7):1099-103. PubMed ID: 15839940
[TBL] [Abstract][Full Text] [Related]
18. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
[TBL] [Abstract][Full Text] [Related]
19. Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways.
Bentolila LA; Prakash R; Mihic-Probst D; Wadehra M; Kleinman HK; Carmichael TS; Péault B; Barnhill RL; Lugassy C
Sci Rep; 2016 Apr; 6():23834. PubMed ID: 27048955
[TBL] [Abstract][Full Text] [Related]
20. Vessel co-option in glioblastoma: emerging insights and opportunities.
Seano G; Jain RK
Angiogenesis; 2020 Feb; 23(1):9-16. PubMed ID: 31679081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
